Canaccord Genuity Reiterates Buy Rating on Castle Biosciences (CSTL) Jan 12, 2026 06:43AM
Canaccord Genuity Reiterates Buy Rating on Castle Biosciences (CSTL) Nov 4, 2025 03:20AM
Castle Biosciences to Present at the Canaccord Genuity 45th Annual Growth Conference Jul 29, 2025 07:00AM
Canaccord Genuity Reiterates Buy Rating on Castle Biosciences (CSTL) Jun 17, 2025 07:06AM
Canaccord Genuity Reiterates Buy Rating on Castle Biosciences (CSTL), 'remain highly bullish' Dec 19, 2024 06:56AM


Nov 5, 2024 06:14AM Canaccord Genuity Reiterates Buy Rating on Castle Biosciences (CSTL)
Oct 29, 2024 06:30AM Castle Biosciences (CSTL) PT Raised to $42 at Canaccord Genuity
Jul 30, 2024 07:00AM Castle Biosciences to Present at the Canaccord Genuity 44th Annual Growth Conference
Nov 8, 2023 01:00PM Castle Biosciences to Present at Upcoming Investor Conferences
Aug 1, 2023 07:00AM Castle Biosciences to Present at the Canaccord Genuity 43rd Annual Growth Conference
Nov 1, 2022 07:00AM Castle Biosciences to Present at Upcoming Investor Conferences
Aug 3, 2022 07:00AM Castle Biosciences to Present at the Canaccord Genuity 42nd Annual Growth Conference
Apr 5, 2022 09:21AM Castle Biosciences (CSTL) PT Lowered to $80 at Canaccord Genuity
Nov 10, 2021 07:00AM Castle Biosciences to Present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
Jul 28, 2021 07:00AM Castle Biosciences to Participate at the Canaccord Genuity 41st Annual Growth Conference
Dec 18, 2020 05:00PM Castle Biosciences Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Dec 16, 2020 06:12AM Castle Biosciences Inc. (CSTL) Prices 4M Share Offering at at $58/Sh
Dec 15, 2020 08:01PM Castle Biosciences Announces Pricing of $232 Million Public Offering of Common Stock
Dec 14, 2020 04:45PM Castle Biosciences (CSTL) Announces Commencement of $125M Proposed Public Offering of Common Stock
Dec 14, 2020 04:45PM Castle Biosciences Announces Commencement of Proposed Public Offering of Common Stock
Nov 5, 2020 07:00AM Castle Biosciences to Present at the Canaccord Genuity 2020 Virtual MedTech & Diagnostics Forum
Aug 5, 2020 07:00AM Castle Biosciences to Present at the Canaccord Genuity 40th Annual Growth Conference
Jul 2, 2020 05:00PM Castle Biosciences Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock
Jun 25, 2020 05:49AM Castle Biosciences Inc. (CSTL) Prices 2M Share Common Offering at $37/Sh
Jun 24, 2020 09:33PM Castle Biosciences Announces Pricing of $74.0 Million Public Offering of Common Stock
Jun 22, 2020 04:34PM Castle Biosciences Inc. (CSTL) Announces Proposed 1.5M Underwritten Public Offering of Common Stock
Jun 22, 2020 04:33PM Castle Biosciences Announces Proposed Underwritten Public Offering of Common Stock
Jan 10, 2020 02:00PM Castle Biosciences (CSTL) PT Raised to $38 at Canaccord Genuity
Dec 27, 2019 08:05AM Castle Biosciences (CSTL) PT Raised to $35 at Canaccord Genuity
Sep 4, 2019 06:29AM Castlight (CSTL) PT Raised to $34 at Canaccord Genuity
Aug 19, 2019 05:24AM Canaccord Genuity Starts Castlight (CSTL) at Buy
Jul 29, 2019 05:42PM Castle Biosciences Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Jul 25, 2019 12:19PM Castle Biosciences Inc. (CSTL) IPO Opens 25% Higher
Jul 25, 2019 05:53AM Castle Biosciences Inc. (CSTL) Prices 4M Share IPO at $16/Sh
Jul 24, 2019 09:38PM Castle Biosciences Announces Pricing of Initial Public Offering